This federal contract award with ID SPE2DB22D3301|SPE2DB25FX4WQ was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,711.35 firm fixed price delivery order is for the pharmaceutical product Gadavist 1 mmol/ml bulk vial 30ml. The contract has an ultimate completion date of November 5, 2024.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.
Generated 2/3/25, 1:21 PM